Albany International Corp /de/ (AIN) · Aug 31, 2026 · Exec change

Albany International CFO takes medical leave as controller assumes acting role

CFO medical leave — CFO leave effective immediately; duration undetermined

Albany International’s CFO is suddenly on medical leave with no end date; an internal accounting executive assumes the acting finance role.

The market expected CFO continuity, and this filing breaks that assumption. There is no earnings or guidance benchmark to score here; the relevant comparison is the standing expectation that the company’s named finance chief would remain in place. Willard Station’s leave begins immediately, and its duration is unknown. 〔0〕

The disruption is partially contained by an internal successor. Controller and Chief Accounting Officer Sean Valashinas becomes acting principal financial officer while retaining his accounting role, limiting the immediate need for an external replacement. 〔1〕

The net read is mildly negative because the key uncertainty is duration, not immediate coverage. Valashinas has relevant public-company accounting experience and has been with Albany International since June 2025, but the filing provides no expected return date and does not say whether the arrangement could become permanent. 〔2〕

This is a new management-risk disclosure rather than a confirmed permanent departure. The acting appointment reduces execution risk in the near term, but the open-ended leave creates uncertainty around finance leadership and the company’s eventual succession plan.

Original filing on SEC EDGAR

More Albany International Corp /de/ news

Albany International CFO takes medical leave as controller assumes acting role | AIN Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.